• Etomidate


    Daniel Jolley.

    2 articles.

    Created February 7, 2021, last updated over 3 years ago.

    Collection: 136, Score: 974, Trend score: 0, Read count: 1219, Articles count: 2, Created: 2021-02-07 23:27:39 UTC. Updated: 2021-02-08 00:09:43 UTC.



    Etomidate (Amidate™) is short-acting intravenous anesthetic agent first developed in 1964. It is available and used in the United Kingdom, Europe, New Zealand, United States, but not Australia.

    Advocates highlight etomidate's hemodynamic stability when used for induction. Critics point to the well-established adrenocortical suppression, and wide-range of suitable alternatives (propofol, ketamine, thiopentone) in trained hands.

    A. Physiochemistry

    • Carboxylated imidazole
    • 2 isomers - only R(+) hypnotic
    • Haemodynamic stability, minimal respiratory depression, cerebral protection, wide margin of safety.
    • Originally formulated in propylene glycol (painful), now in soybean lipid.

    B. Pharmacokinetics

    1. Dose - 0.3 mg/kg (0.1-0.4 mg/kg)
    2. Absorption - IV
    3. Distribution - 4 L/kg
    4. Protein binding - 75% (like thiopentone)
    5. Onset 30-60s ; Offset
    6. Metabolism - alpha1 ½ 2.5m, alpha2 ½ 30m, tß½ 3.5h; hepatic ester hydrolysis of ester side chain.
    7. Clearance - 20 mL/kg/min

    C. Pharmacodynamics

    1. Mech - probably by GABAa receptors.
    2. CNS - hypnosis; no analgesic action; ⇣ CBF and CMRO2
    3. CVS - stable; may have slight dec MAP 15% due to ⇣ SVR.
    4. Resp - minimal; sometimes brief hypoventilation or apnoea post-induction.
    5. Endo - adrenocortical suppression - inhibits 11ß-hydroxylase (11-deoxycortisol → cortisol). Temporary & reversed by vit C.
      • ⇡ ICU mortality when used for sedation.
    6. SEs - excitatory phenom, involuntary muscle movement (50%), PONV (30%), thrombophlebitis (20%), pain on injection.
    Daniel Jolley  Daniel Jolley
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    Collected Articles

    • Prehosp Emerg Care · Jul 2003

      The use of etomidate for prehospital rapid-sequence intubation.

      Prehospital hypoxia and hypotension increase morbidity and mortality in head-injured patients. Etomidate is a sedative agent with increasing use for emergent rapid-sequence intubation (RSI) because of its favorable hemodynamic profile. This prospective, observational study documents the authors' preliminary experience with etomidate as part of an aeromedical RSI protocol. ⋯ An improvement in SBP after RSI with etomidate was observed (123 mm Hg to 136 mm Hg, p = 0.011) with a 9% incidence of hypotension, defined as a decrease in SBP to 90 mm Hg or less. Graphic analysis of individual SBP-time plots reveals hemodynamic stability, especially in patients with lower initial SBP values. These data suggest that the use of etomidate as part of a prehospital RSI protocol is associated with hemodynamic stability and a low incidence of hypotension.

      keep going… or not…

    • Anesthesia and analgesia · Sep 1985

      Randomized Controlled Trial Comparative Study Clinical Trial

      Etomidate versus thiopental for induction of anesthesia.

      Hemodynamic changes and side effects of anesthesia induction with etomidate or thiopental were evaluated in 83 ASA class I or II patients. Patients were randomly assigned to one of 12 groups according to pretreatment drug (fentanyl, 100 micrograms, or normal saline intravenously), induction agent (etomidate, 0.4 mg/kg, or thiopental, 4 mg/kg), and maintenance anesthetic technique (isoflurane-oxygen, isoflurane-nitrous oxide-oxygen, or fentanyl-nitrous oxide-oxygen). The purpose of this experiment, of factorial design, was to evaluate the combined effects of two or more experimental variables used simultaneously and to observe interaction effects. ⋯ Patients in whom anesthesia was induced with etomidate had a greater incidence of pain on injection and myoclonus and a lesser incidence of apnea than patients in whom anesthesia was induced with thiopental. Fentanyl pretreatment significantly decreased the incidence of pain on injection and myoclonus, but it increased the incidence of apnea when anesthesia was induced with etomidate. The incidence of postoperative nausea and vomiting was similar after thiopental and etomidate and was unaffected by fentanyl pretreatment. (ABSTRACT TRUNCATED AT 250 WORDS)

      expand abstract… mark as read…

    collapse collection…